PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 29, 2026Cells0 citationsOpen Access

Potential Anxiolytic Effects of Selected Inositol Stereoisomers—A Narrative Review

View Full Paper
MDMaria DerkaczewKZKamila Zglejc‐WaszakPPPiotr Podlasz

Key Points

  • The aim is to evaluate the potential anxiolytic effects of selected inositol stereoisomers on anxiety-related outcomes.
  • Narrative review conducted using structured search of biomedical bibliographic databases.
  • Focused on myo-inositol, scyllo-inositol, and D-chiro-inositol.
  • Assessed literature related to anxiety outcomes.
  • Evidence suggests that myo-inositol shows biological plausibility for anxiolytic effects.
  • Data on scyllo-inositol and D-chiro-inositol is limited, particularly regarding anxiety.
  • Overall findings are heterogeneous and do not support definitive clinical conclusions.

Abstract

Background: Anxiety is a frequent clinical problem that becomes disabling when excessive or persistent. Cyclitols are naturally occurring polyhydroxy compounds, and inositols are the most abundant cyclitols in eukaryotic cells; several stereoisomers have been proposed as candidates for CNS-relevant effects. Methods: A narrative review was conducted using a structured search of biomedical bibliographic databases. The search was centered on myo-inositol, scyllo-inositol, and D-chiro-inositol in relation to anxiety-related outcomes. Results: The retrieved literature suggests some biological plausibility for anxiolytic effects of selected inositol stereoisomers through pathways related to intracellular signaling and neurotransmission. However, the available evidence is uneven and remains limited. The most informative findings concern myo-inositol and include both preclinical and clinical studies, whereas data on scyllo-inositol and D-chiro-inositol are scarce, particularly in relation to anxiety-related outcomes. Conclusions: Current evidence suggests a possible anxiolytic role of selected inositol stereoisomers; however, the existing data are limited and heterogeneous, and do not allow for definitive clinical conclusions. Further research is required.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Derkaczew et al. (2026) studied this question.

synapsesocial.com/papers/6a192dd1fab5b468c4416c8ehttps://doi.org/10.3390/cells15110970
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Acute inositol induces anxiety in rats1996 · 3 citations
  2. 2Inositol treatment of post-traumatic stress disorder1996 · 64 citations
  3. 3Anxiety Disorders2022 · 528 citations
  4. 4Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience2016 · 151 citations
  5. 5Effects of myo-Inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study1999 · 39 citations